| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Soparkar Peter | CHIEF OPERATING OFFICER | C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY | /s/ Aneta Fergson, Attorney-in-Fact | 16 May 2025 | 0001736315 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADVM | Common Stock | Sale | $5,920 | -2,960 | -7% | $2.00 | 39,154 | 15 May 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units. |
| F2 | Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.9701 to $2.01. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |